Peter Birner
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.5%
- Lymphatic System and Diseases
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
Papers in
- Oncology 60
- Lymphatic System and Diseases 15
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 8
-
- Angiogenesis and VEGF in Cancer 11
- Co-authors
- Sebastian F. Schoppmann (46 shared papers)Monika Schindl (22 shared papers)Matthias Preusser (53 shared papers)Anna S. Berghoff (41 shared papers)Georg Oberhuber (15 shared papers)Johannes A. Hainfellner (32 shared papers)Andreas Obermair (7 shared papers)G. Breitenecker (10 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Clinical & Experimental Metastasis (7 papers)International Journal of Cancer (6 papers)Cancer (5 papers)PLoS ONE (5 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Peter Birner
169 papers receiving 9.2k citations
Peter Birner's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 1.9k
- Oncology 3.4k
- Genetics 917
- Pulmonary and Respiratory Medicine 1.7k
- Immunology 1.1k
Countries citing papers authored by Peter Birner
This map shows the geographic impact of Peter Birner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Birner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Birner more than expected).
Fields of papers citing papers by Peter Birner
This network shows the impact of papers produced by Peter Birner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Birner. The network helps show where Peter Birner may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Birner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis Hit paper breakdown → | 2002 | 668 |
| 2 | Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Hit paper breakdown → | 2000 | 556 |
| 3 | Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy Hit paper breakdown → | 2015 | 448 |
| 4 | 2004 | 405 | |
| 5 | Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. | 2002 | 344 |
| 6 | Quantitative evidence for early metastatic seeding in colorectal cancer Hit paper breakdown → | 2019 | 305 |
| 7 | 2015 | 238 | |
| 8 | 2017 | 184 | |
| 9 | 2011 | 181 | |
| 10 | 2016 | 178 | |
| 11 | 2001 | 172 | |
| 12 | 2012 | 155 | |
| 13 | Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. | 2003 | 154 |
| 14 | 2012 | 148 | |
| 15 | 2003 | 130 | |
| 16 | 2003 | 124 | |
| 17 | Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. | 2003 | 123 |
| 18 | Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. | 2001 | 115 |
| 19 | 2016 | 106 | |
| 20 | 2017 | 97 |
About Peter Birner
Peter Birner is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 171 papers that have together received 9.3k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (16 papers), Glioma Diagnosis and Treatment (16 papers), Lymphatic System and Diseases (15 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.4k citations), Genetics (917 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Immunology (1.1k citations). Peter Birner has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Sebastian F. Schoppmann, Monika Schindl, Matthias Preusser, Anna S. Berghoff, Georg Oberhuber, Johannes A. Hainfellner, Andreas Obermair, G. Breitenecker, Georg Widhalm and Karin Dieckmann. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Experimental Metastasis, International Journal of Cancer, Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.